TOP2A Gene

Name topoisomerase (DNA) II alpha 170kDa
Description This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsional stress that occurs during DNA transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex DNA which allows the strands to pass through one another, thus altering the topology of DNA. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this form, alpha, is localized to chromosome 17 and the beta gene is localized to chromosome 3. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also play a role in ataxia-telangiectasia. [provided by RefSeq, Jul 2010]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nTOP2A (DNA topoisomerase IIα) is a critical enzyme that regulates DNA topology by catalyzing transient double‐stranded DNA breaks and re‐ligation to resolve supercoils and catenanes. Its dynamic activity is essential during DNA replication and mitosis, ensuring proper decatenation of newly replicated sister chromatids and accurate chromosome segregation. Structural and biochemical studies reveal that TOP2A markedly bends its DNA substrate and undergoes quantized conformational transitions—processes that depend on ATP hydrolysis—and that its association with centromeric and telomeric chromatin is modulated by chromatin‐remodeling factors and checkpoint effectors. Disruptions in TOP2A function can result in untimely anaphase bridges and cell cycle delays, ultimately compromising genomic integrity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAberrant TOP2A expression and gene alterations are commonly observed in a wide spectrum of malignancies—including breast, hepatocellular, pancreatic, bladder, and adrenocortical cancers—and are frequently associated with aggressive tumor behavior and chemoresistance. Co‐amplification with oncogenes such as HER2, activation of pathways like β‐catenin signaling, and specific genomic gains contribute to its utility as a prognostic biomarker and predictor of treatment response, especially to anthracycline‐based therapies and other TOP2 inhibitors. Moreover, TOP2A dysregulation plays a role in leukemogenesis through its susceptibility to poisoning by metabolites such as 1,4‐benzoquinone, further emphasizing its relevance as a clinical target and as a key component in stratifying patients for individualized therapy."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "14", "end_ref": "29"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nTherapeutic targeting of TOP2A has emerged as a promising strategy in cancer treatment. Novel small‐molecule inhibitors, including multitarget agents such as naphthalimides and nitidine chloride, have been developed to interfere with TOP2A’s catalytic cycle and promote the accumulation of lethal DNA lesions. In parallel, regulatory mechanisms—such as p21‐mediated transcriptional repression, isoform‐specific modifications, and modulation by RNA‐binding proteins—finely tune TOP2A expression and activity, thereby influencing drug sensitivity and apoptotic responses. Continued elucidation of TOP2A’s regulatory network and its interplay with DNA repair pathways is critical for optimizing chemotherapeutic regimens and overcoming treatment resistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "30", "end_ref": "35"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Morten O Christensen, Morten K Larsen, Hans Ullrich Barthelmes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dynamics of human DNA topoisomerases IIalpha and IIbeta in living cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.200112023"}], "href": "https://doi.org/10.1083/jcb.200112023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11927602"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11927602"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jennifer M Spence, Ricky Critcher, Thomas A Ebersole, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Co-localization of centromere activity, proteins and topoisomerase II within a subdomain of the major human X alpha-satellite array."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/emboj/cdf511"}], "href": "https://doi.org/10.1093/emboj/cdf511"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12356743"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12356743"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Adam J Carpenter, Andrew C G Porter "}, {"type": "b", "children": [{"type": "t", "text": "Construction, characterization, and complementation of a conditional-lethal DNA topoisomerase IIalpha mutant human cell line."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Cell (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1091/mbc.e04-08-0732"}], "href": "https://doi.org/10.1091/mbc.e04-08-0732"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15456904"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15456904"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "A Kathleen McClendon, A Chapin Rodriguez, Neil Osheroff "}, {"type": "b", "children": [{"type": "t", "text": "Human topoisomerase IIalpha rapidly relaxes positively supercoiled DNA: implications for enzyme action ahead of replication forks."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M503320200"}], "href": "https://doi.org/10.1074/jbc.M503320200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16188892"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16188892"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Hongchang Li, Yun Wang, Xiaoqi Liu "}, {"type": "b", "children": [{"type": "t", "text": "Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M709007200"}], "href": "https://doi.org/10.1074/jbc.M709007200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18171681"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18171681"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Kuntian Luo, Jian Yuan, Junjie Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Topoisomerase IIalpha controls the decatenation checkpoint."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb1828"}], "href": "https://doi.org/10.1038/ncb1828"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19098900"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19098900"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Jing Ye, Christelle Lenain, Serge Bauwens, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TRF2 and apollo cooperate with topoisomerase 2alpha to protect human telomeres from replicative damage."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2010.05.032"}], "href": "https://doi.org/10.1016/j.cell.2010.05.032"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20655466"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20655466"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Timothy J Wendorff, Bryan H Schmidt, Pauline Heslop, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The structure of DNA-bound human topoisomerase II alpha: conformational mechanisms for coordinating inter-subunit interactions with DNA cleavage."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Biol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jmb.2012.07.014"}], "href": "https://doi.org/10.1016/j.jmb.2012.07.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22841979"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22841979"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Emily C Dykhuizen, Diana C Hargreaves, Erik L Miller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BAF complexes facilitate decatenation of DNA by topoisomerase IIα."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature12146"}], "href": "https://doi.org/10.1038/nature12146"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23698369"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23698369"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Ronan Broderick, Jadwiga Nieminuszczy, Andrew N Blackford, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TOPBP1 recruits TOP2A to ultra-fine anaphase bridges to aid in their resolution."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms7572"}], "href": "https://doi.org/10.1038/ncomms7572"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25762097"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25762097"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Christian F Nielsen, Diana Huttner, Anna H Bizard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PICH promotes sister chromatid disjunction and co-operates with topoisomerase II in mitosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms9962"}], "href": "https://doi.org/10.1038/ncomms9962"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26643143"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26643143"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Nguyen Ngoc Hoa, Tsubasa Shimizu, Zhong Wei Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mre11 Is Essential for the Removal of Lethal Topoisomerase 2 Covalent Cleavage Complexes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2016.10.011"}], "href": "https://doi.org/10.1016/j.molcel.2016.10.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27814490"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27814490"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Andres Canela, Yaakov Maman, Shar-Yin N Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Topoisomerase II-Induced Chromosome Breakage and Translocation Is Determined by Chromosome Architecture and Transcriptional Activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2019.04.030"}], "href": "https://doi.org/10.1016/j.molcel.2019.04.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31202577"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31202577"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "R Hunter Lindsey, Kenneth D Bromberg, Carolyn A Felix, et al. "}, {"type": "b", "children": [{"type": "t", "text": "1,4-Benzoquinone is a topoisomerase II poison."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi049756r"}], "href": "https://doi.org/10.1021/bi049756r"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15182198"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15182198"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Ann S Knoop, Helle Knudsen, Eva Balslev, et al. "}, {"type": "b", "children": [{"type": "t", "text": "retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2005.11.007"}], "href": "https://doi.org/10.1200/JCO.2005.11.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16234514"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16234514"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Mariano Monzo, Salut Brunet, Alvaro Urbano-Ispizua, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2005-08-3272"}], "href": "https://doi.org/10.1182/blood-2005-08-3272"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16507781"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16507781"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Jianhui Shi, Haiyan Liu, Myra Wilkerson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Pathol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humpath.2007.01.025"}], "href": "https://doi.org/10.1016/j.humpath.2007.01.025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17512033"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17512033"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "René M Linka, Andrew C G Porter, Arsen Volkov, et al. "}, {"type": "b", "children": [{"type": "t", "text": "C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkm102"}], "href": "https://doi.org/10.1093/nar/gkm102"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17526531"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17526531"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Edurne Arriola, Caterina Marchio, David S P Tan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lab Invest (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/labinvest.2008.19"}], "href": "https://doi.org/10.1038/labinvest.2008.19"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18332872"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18332872"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Britta Weigelt, Bas Kreike, Jorge S Reis-Filho "}, {"type": "b", "children": [{"type": "t", "text": "Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res Treat (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10549-008-0197-9"}], "href": "https://doi.org/10.1007/s10549-008-0197-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18815879"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18815879"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Nathalie Wong, Winnie Yeo, Wai-Lap Wong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.23968"}], "href": "https://doi.org/10.1002/ijc.23968"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19003983"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19003983"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "F P O'Malley, S Chia, D Tu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Natl Cancer Inst (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jnci/djp067"}], "href": "https://doi.org/10.1093/jnci/djp067"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19401546"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19401546"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Michael F Press, Guido Sauter, Marc Buyse, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2009.27.5644"}], "href": "https://doi.org/10.1200/JCO.2009.27.5644"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21189395"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21189395"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Subramanya Srikantan, Kotb Abdelmohsen, Eun Kyung Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Translational control of TOP2A influences doxorubicin efficacy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.05639-11"}], "href": "https://doi.org/10.1128/MCB.05639-11"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21768308"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21768308"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Angelo Di Leo, Christine Desmedt, John M S Bartlett, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lancet Oncol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S1470-2045(11)70231-5"}], "href": "https://doi.org/10.1016/S1470-2045(11"}, {"type": "t", "text": "70231-5) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21917518"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21917518"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Karin Milde-Langosch, Thomas Karn, Volkmar Müller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res Treat (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10549-012-2296-x"}], "href": "https://doi.org/10.1007/s10549-012-2296-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23135572"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23135572"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Ravat Panvichian, Anchalee Tantiwetrueangdet, Napat Angkathunyakul, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TOP2A amplification and overexpression in hepatocellular carcinoma tissues."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Res Int (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2015/381602"}], "href": "https://doi.org/10.1155/2015/381602"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25695068"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25695068"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Yao-Fei Pei, Xi-Min Yin, Xi-Qiang Liu "}, {"type": "b", "children": [{"type": "t", "text": "TOP2A induces malignant character of pancreatic cancer through activating β-catenin signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta Mol Basis Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbadis.2017.10.019"}], "href": "https://doi.org/10.1016/j.bbadis.2017.10.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29045811"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29045811"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Li-Min Liu, Dan-Dan Xiong, Peng Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "DNA topoisomerase 1 and 2A function as oncogenes in liver cancer and may be direct targets of nitidine chloride."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2018.4531"}], "href": "https://doi.org/10.3892/ijo.2018.4531"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30132517"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30132517"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Victor T Solovyan, Zinayida A Bezvenyuk, Antero Salminen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of topoisomerase II in the excision of DNA loop domains during apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110621200"}], "href": "https://doi.org/10.1074/jbc.M110621200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11940566"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11940566"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Hongming Zhu, Bey-Dih Chang, Takeshi Uchiumi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of promoter elements responsible for transcriptional inhibition of polo-like kinase 1 and topoisomerase IIalpha genes by p21(WAF1/CIP1/SDI1)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2002)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12429910"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12429910"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Eriko Toyoda, Shigehide Kagaya, Ian G Cowell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M803936200"}], "href": "https://doi.org/10.1074/jbc.M803936200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18596031"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18596031"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Zhuo Chen, Xin Liang, Huanying Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A new class of naphthalimide-based antitumor agents that inhibit topoisomerase II and induce lysosomal membrane permeabilization and apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Med Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/jm100025u"}], "href": "https://doi.org/10.1021/jm100025u"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20170164"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20170164"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Junko Murai, Shar-yin N Huang, Benu Brata Das, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111.333963"}], "href": "https://doi.org/10.1074/jbc.M111.333963"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22375014"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22375014"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Anu Hangas, Koit Aasumets, Nina J Kekäläinen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ciprofloxacin impairs mitochondrial DNA replication initiation through inhibition of Topoisomerase 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gky793"}], "href": "https://doi.org/10.1093/nar/gky793"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30169847"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30169847"}]}]}]}
Synonyms TOP2, TP2A
Proteins TOP2A_HUMAN
NCBI Gene ID 7153
API
Download Associations
Predicted Functions View TOP2A's ARCHS4 Predicted Functions.
Co-expressed Genes View TOP2A's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View TOP2A's ARCHS4 Predicted Functions.

Functional Associations

TOP2A has 19,020 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 127 datasets.

Click the + buttons to view associations for TOP2A from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Achilles Cell Line Gene Essentiality Profiles cell lines with fitness changed by TOP2A gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of TOP2A gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of TOP2A gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of TOP2A gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of TOP2A gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of TOP2A gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of TOP2A gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of TOP2A gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of TOP2A gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of TOP2A gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CCLE Cell Line Gene Mutation Profiles cell lines with TOP2A gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset.
CCLE Cell Line Proteomics Cell lines associated with TOP2A protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with TOP2A gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of TOP2A gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of TOP2A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of TOP2A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of TOP2A gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing TOP2A protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing TOP2A protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores cellular components containing TOP2A protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing TOP2A protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with TOP2A protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with TOP2A protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
CORUM Protein Complexes protein complexs containing TOP2A protein from the CORUM Protein Complexes dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of TOP2A gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with TOP2A gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with TOP2A gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with TOP2A gene/protein from the curated CTD Gene-Disease Associations dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of TOP2A protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores diseases associated with TOP2A gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with TOP2A gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with TOP2A gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with TOP2A gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with TOP2A gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
DrugBank Drug Targets interacting drugs for TOP2A protein from the curated DrugBank Drug Targets dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at TOP2A gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of TOP2A gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of TOP2A gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing TOP2A from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with TOP2A gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with TOP2A gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of TOP2A gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with TOP2A gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing TOP2A from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of TOP2A gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of TOP2A gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of TOP2A gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of TOP2A gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of TOP2A gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of TOP2A gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving TOP2A gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving TOP2A gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving TOP2A gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing TOP2A protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing TOP2A protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing TOP2A protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by TOP2A gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by TOP2A gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by TOP2A gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of TOP2A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of TOP2A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of TOP2A gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of TOP2A gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
Guide to Pharmacology Chemical Ligands of Receptors ligands (chemical) binding TOP2A receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset.
HMDB Metabolites of Enzymes interacting metabolites for TOP2A protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of TOP2A gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of TOP2A gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of TOP2A protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of TOP2A gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
HPO Gene-Disease Associations phenotypes associated with TOP2A gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for TOP2A from the curated Hub Proteins Protein-Protein Interactions dataset.
HuBMAP Azimuth Cell Type Annotations cell types associated with TOP2A gene from the HuBMAP Azimuth Cell Type Annotations dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with TOP2A gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
IMPC Knockout Mouse Phenotypes phenotypes of mice caused by TOP2A gene knockout from the IMPC Knockout Mouse Phenotypes dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for TOP2A protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of TOP2A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEA Substrates of Kinases kinases that phosphorylate TOP2A protein from the curated KEA Substrates of Kinases dataset.
Kinase Library Serine Threonine Kinome Atlas kinases that phosphorylate TOP2A protein from the Kinase Library Serine Threonine Atlas dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of TOP2A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of TOP2A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with TOP2A gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of TOP2A gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of TOP2A gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of TOP2A gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of TOP2A gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Curated Protein Localization Annotations cellular components containing TOP2A protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain TOP2A protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by TOP2A gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting TOP2A gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of TOP2A gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of TOP2A gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
MSigDB Cancer Gene Co-expression Modules co-expressed genes for TOP2A from the MSigDB Cancer Gene Co-expression Modules dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of TOP2A gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of TOP2A gene from the NIBR DRUG-seq U2OS MoA Box dataset.
NURSA Protein Complexes protein complexs containing TOP2A protein recovered by IP-MS from the NURSA Protein Complexes dataset.
OMIM Gene-Disease Associations phenotypes associated with TOP2A gene from the curated OMIM Gene-Disease Associations dataset.
PANTHER Pathways pathways involving TOP2A protein from the PANTHER Pathways dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for TOP2A from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of TOP2A gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of TOP2A gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving TOP2A protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving TOP2A protein from the Wikipathways PFOCR 2024 dataset.
Phosphosite Textmining Biological Term Annotations biological terms co-occuring with TOP2A protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset.
PhosphoSitePlus Substrates of Kinases kinases that phosphorylate TOP2A protein from the curated PhosphoSitePlus Substrates of Kinases dataset.
PID Pathways pathways involving TOP2A protein from the PID Pathways dataset.
Reactome Pathways 2014 pathways involving TOP2A protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving TOP2A protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of TOP2A gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of TOP2A gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles cell types and tissues with high or low expression of TOP2A gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at TOP2A gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of TOP2A gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of TOP2A gene from the RummaGEO Gene Perturbation Signatures dataset.
Sanger Dependency Map Cancer Cell Line Proteomics cell lines associated with TOP2A protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs drug perturbations changing phosphorylation of TOP2A protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs dataset.
Tabula Sapiens Gene-Cell Associations cell types with high or low expression of TOP2A gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of TOP2A gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of TOP2A gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of TOP2A gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of TOP2A protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of TOP2A protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of TOP2A protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of TOP2A protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with TOP2A protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with TOP2A protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2014 pathways involving TOP2A protein from the Wikipathways Pathways 2014 dataset.
WikiPathways Pathways 2024 pathways involving TOP2A protein from the WikiPathways Pathways 2024 dataset.